A research committee has laid out a plan to successfully eradicate hepatitis B and C from the United States by 2030. The plan suggests that the federal government acquire license rights for expensive drugs used to treat these diseases.
A research committee has laid out a plan to successfully eradicate hepatitis B and C from the United States by 2030. The plan suggests that the federal government acquire license rights for expensive drugs used to treat these diseases.